New drug trial offers hope for painful skin condition
NCT ID NCT07417917
Summary
This study is testing whether QLS12010 capsules can help control moderate-to-severe hidradenitis suppurativa, a painful skin condition. The trial will involve 102 adults who haven't responded well to standard antibiotic treatments. Researchers will compare different doses against a placebo to see how well the drug reduces skin lesions and how safe it is over 32 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULTS WITH MODERATE-TO-SEVERE HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.